A NEW head of the region’s cancer alliance – which improve cancer patient’s outcomes both in terms of survival and experience of care – has been appointed.

David Loughton, who is the longest serving chief executive in the NHS, having been a CEO for 31 years, has been announced as the new chairman of the West Midlands Cancer Alliance.

The Alliance was established in 2016 to provide leadership and ensure successful delivery of the programme of work, and is the decision-making body in relation to the planning and delivery of the cancer task force strategy across the region.

Mr Loughton, who started his career in the NHS in 1986 and is currently chief executive of The Royal Wolverhampton NHS Trust, said: “I am delighted and honoured to be appointed chair of the West Midlands Cancer Alliance.

“These are challenging times for the NHS, and I am looking forward to working with the team to ensure that the best cancer services are provided from the most appropriate locations for people across the West Midlands.”

Dr Andrea Gordon, programme director at West Midlands Cancer Alliance, added: “David brings a wealth of experience and knowledge about the NHS to this role.

“His extensive skills, knowledge and experience will, I am sure, enable him to shape the future of high quality and sustainable cancer services for the people in the Midlands.

“He is a passionate supporter of clinical engagement and digitalisation of pathology services.”

Mr Loughton, who is also a member of the National Institute for Health Research Advisory Board, will replace Dame Julie Moore after her decision to step down from the role.